4.7 Article

Presenilin-1 familial Alzheimer's disease mutation alters hippocampal neurogenesis and memory function in CCL2 null mice

Journal

BRAIN BEHAVIOR AND IMMUNITY
Volume 49, Issue -, Pages 311-321

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbi.2015.06.014

Keywords

Hippocampus; Neurogliogenesis; Chemokine; Morris water maze; Long-term potentiation

Funding

  1. NIH [AG043540, DA028555, NS036126, NS034239, MH064570, NS043985, MH062261]
  2. DOD [421-20-09A]
  3. Carol Swarts Emerging Neuroscience Fund
  4. start-up funds from the Department of Pharmacology and Experimental Neuroscience
  5. Shoemaker Award for Neurodegenerative Research

Ask authors/readers for more resources

Aberrations in hippocampal neurogenesis are associated with learning and memory, synaptic plasticity and neurodegeneration in Alzheimer's disease (AD). However, the linkage between them, beta-amyloidosis and neuroinflammation is not well understood. To this end, we generated a mouse over-expressing familial AD (FAD) mutant human presenilin-1 (PS1) crossed with a knockout (KO) of the CC-chemokine ligand 2 (CCL2) gene. The PS1/CCL2KO mice developed robust age-dependent deficits in hippocampal neurogenesis associated with impairments in learning and memory, synaptic plasticity and long-term potentiation. Neurogliogenesis gene profiling supported beta-amyloid independent pathways for FAD-associated deficits in hippocampal neurogenesis. We conclude that these PS1/CCL2KO mice are suitable for studies linking host genetics, immunity and hippocampal function. (C) 2015 The Authors. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available